ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2021

[Curative radiotherapy of oligometastatic cancer: long-term results of the SABR-COMET phase II trial].

Jürgen DunstPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.